Ronnie Hershman - 18 Mar 2026 Form 3 Insider Report for Nasus Pharma Ltd (NSRX)

Reporting relationship: Director
Issuer ticker: NSRX
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 27 Mar 2026, 20:56:42 UTC
Source filing: View source filing
Reporting owner signature: /s/ Ronnie Hershman

Key filing fact

Ronnie Hershman filed Form 3 for Nasus Pharma Ltd (NSRX) on 27 Mar 2026.

Key facts

This page summarizes Ronnie Hershman's Form 3 filing for Nasus Pharma Ltd (NSRX).
0 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 27 Mar 2026, 20:56.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002086512 Primary reporting owner

Hershman Ronnie

Relationship: Director
Address: P.O. BOX 284, TEL-AVIV-YAFO, ISRAEL
Signature: /s/ Ronnie Hershman
Signature date: 27 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NSRX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 909,156
Date: 18 Mar 2026
Ownership: By Hershman Holdings, LLC
Footnotes: F1

NSRX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 429,307
Date: 18 Mar 2026
Ownership: By Phoenix Solutions Ltd.
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NSRX holding Derivative

Share options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 63,017
Exercise price: $4.30
Footnotes: F3

NSRX holding Derivative

Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: By Hershman Holdings, LLC
Underlying class: Ordinary Shares
Underlying amount: 17,970
Exercise price: $6.53
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents ordinary shares of the Issuer, no par value ("Ordinary Shares") directly held by Hershman Holdings, LLC. Dr. Ronnie Hershman, as the managing member of Hershman Holdings, LLC, may be deemed to beneficially own the Ordinary Shares owned directly by Hershman Holdings, LLC.

Footnote F2

Represents Ordinary Shares directly held by Phoenix Solutions Ltd. Dr. Ronnie Hershman, as a controlling shareholder of Phoenix Solutions Ltd., may be deemed to beneficially own the Ordinary Shares owned directly by Phoenix Solutions Ltd.

Footnote F3

The options to purchase 63,017 Ordinary Shares were granted on May 6, 2020, with 25% of the total grant vesting on May 6, 2021, and the remaining 75% vesting in equal quarterly installments of 6.25% thereafter. As of March 18, 2026, 63,017 options are vested and exercisable at an exercise price of $4.297 per share, expiring May 6, 2030.

Footnote F4

The warrants to purchase up to 17,970 Ordinary Shares (the "Warrants") were issued on February 13, 2026. The Warrants have an exercise price of $6.53 per share, were immediately exercisable, and will expire upon the earlier of two years from the date of issuance and 30 trading days following the Issuer's announcement of the top-line results of the Issuer's NS002 Pivotal Study. The Warrants are directly held by Hershman Holdings, LLC. Dr. Ronnie Hershman, as the managing member of Hershman Holdings, LLC, may be deemed to beneficially own the Warrants owned directly by Hershman Holdings, LLC.